Pfizer to buy Hospira for $15 billion to bolster hospital products

(Reuters) – Pfizer Inc said it would buy Hospira Inc for about $15 billion to boost its portfolio of generic injectable drugs and copies of biotech medicines.




Source: Business

Leave a Reply

Your email address will not be published. Required fields are marked *

5 × 4 =